Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Total Non-Current Liabilities (2023 - 2024)

Historic Total Non-Current Liabilities for BioScience Health Innovations (BHIC) over the last 2 years, with Q3 2024 value amounting to $10947.0.

  • BioScience Health Innovations' Total Non-Current Liabilities rose 3629.23% to $10947.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $10947.0, marking a year-over-year increase of 3629.23%. This contributed to the annual value of $13074.0 for FY2023, which is 28061.14% up from last year.
  • As of Q3 2024, BioScience Health Innovations' Total Non-Current Liabilities stood at $10947.0, which was up 3629.23% from $9011.0 recorded in Q2 2024.
  • In the past 5 years, BioScience Health Innovations' Total Non-Current Liabilities ranged from a high of $15235.0 in Q1 2023 and a low of $901.0 during Q2 2023